Publications:

Poziotinib Inhibits HER2-Mutant-Driven Therapeutic Resistance and Multiorgan Metastasis in Breast Cancer.

Cancer Research

Kalra, Rashi R; Chen, Ching Hui CH; Wang, Junkai J; Salam, Ahmad Bin AB; Dobrolecki, Lacey E LE; Lewis, Alaina A; Sallas, Christina C; Yates, Clayton C CC; Gutierrez, Carolina C; Karanam, Balasubramanyam B; Anurag, Meenakshi M; Lim, Bora B; Ellis, Matthew J MJ; Kavuri, Shyam M SM

Publication Date: 2022-08-16

Variant appearance in text: HER2: W825*

PubMed Link: 35736563

Variant Present in the following documents:

• can-21-3106_supplementary_data_suppst1.xlsx, sheet 2

View BVdb publication page

Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study.

Journal Of Oncology

Murray, Samuel S; Bobos, Mattheos M; Angouridakis, Nikolaos N; Nikolaou, Angelos A; Linardou, Helena H; Razis, Evangelia E; Fountzilas, George G

Publication Date: 2010

Variant appearance in text: HER2: W825X

PubMed Link: 21274259

Variant Present in the following documents:

• Main text
• JO2010-709678.pdf

View BVdb publication page